Measuring the return from pharmaceutical innovation 2015 Transforming R&D returns in uncertain times
No appointment necessary How the IoT and patient-generated data can unlock health care value
Global employer services
Among the most serious challenges businesses face today is compliance with multifaceted tax laws and labor regulations. Deloitte offers well-rounded plans and program development strategies that can help transform global employment programs in a tax- and cost-efficient manner.
Process and Organizational Design
Our industry experts provide clients with customized solutions in organizational structure and process design.
Enterprise Risk Management (ERM)
In Enterprise Risk Management, we offer dedicated services to our clients to help them take the necessary measures to mitigate risks as well as integrate their risk management procedures into their processes and strategies by managing value-added risks.
Measuring the return from pharmaceutical innovation
The fifth annual study of the pharmaceutical industry’s performance in generating a return from its significant investment in R&D. The report allows industry leaders to understand the drivers of successful R&D strategies that are tangible and, most importantly, actionable.
Strategic alliances in Life Sciences
Life sciences companies have adopted a multi-track approach to cope with the current and anticipated drop in sales revenue. Next to classic mergers and acquisitions (M&A) Strategic Alliances have proven to be a viable alternative in coping with these challenges.
The tail wagging the dog
Outpatient satisfaction levels are trending downward. Consumers are starting to exert their power by making more demands on the health care provider-patient relationship and expecting to be treated in much the same way they are accustomed to being treated in their daily interactions with retailers.